FDA批准B细胞单克隆抗体用于治疗两种罕见疾病
被引量：1
摘要
美国食品药品管理局（FDA）目前批准B细胞单克隆抗体（利妥昔单抗）联合糖皮质激素（类固醇）治疗患有引起血管炎症（血管炎）的罕见韦格纳肉芽肿（WG）和镜下型多血管炎（MPA）患者。
出处
《药学与临床研究》
2011年第4期331-331,共1页
Pharmaceutical and Clinical Research
同被引文献52
-
1Jennette JC,Falk RJ,Bacon PA,et al.2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J].Arthritis Rheum,2013,65(1):1-11.
-
2Chen M,Yu F,Zhang Y,et al.Clinical[corrected]and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides:a study of 426 patients from a single centre[J].Postgrad Med J,2005,81(961):723-727.
-
3Feehally J,Wheeler DC,Walls J,et al.A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies[J].Clin Nephrol,1987,27(4):214-215.
-
4Jennette JC,Falk RJ,Andrassy K,et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference[J].Arthritis Rheum,1994,37(2):187-192.
-
5Frohnert PP,Sheps SG.Long-term follow-up study of periarteritis nodosa[J].Am J Med,1967,43(1):8-14.
-
6Mukhtyar C,Flossmann O,Hellmich B,et al.Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis:a systematic review by the European League Against Rheumatism systemic vasculitis task force[J].Ann Rheum Dis,2008,67(7):1004-1010.
-
7Hellmich B,Flossmann O,Gross WL,et al.EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis:focus on anti-neutrophil cytoplasm antibody-associated vasculitis[J].Ann Rheum Dis,2007,66(5):605-617.
-
8Mukhtyar C,Guillevin L,Cid MC,et al.EULAR recommendations for the management of large vessel vasculitis[J].Ann Rheum Dis,2009,68(3):318-323.
-
9Luqmani RA,Bacon PA,Moots RJ,et al.Birmingham Vasculitis Activity Score(BVAS)in systemic necrotizing vasculitis[J].QJM,1994,87(11):671-678.
-
10Walsh M,Merkel PA,Peh CA,et al.Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis(PEXIVAS):protocol for a randomized controlled trial[J].Trials,2013,14:73.
二级引证文献6
-
1李杰,唐怡,苟慎菊.糖皮质激素联合环磷酰胺方案治疗抗中性粒细胞胞质抗体相关小血管炎的临床疗效[J].临床合理用药杂志,2017,10(21):43-45. 被引量：8
-
2邱岭.抗中性粒细胞胞质抗体相关性新月体肾炎治疗反应及远期预后的影响因素[J].中西医结合心血管病电子杂志,2017,5(23):185-185.
-
3赵海慧.免疫抑制剂在原发性小血管炎治疗中的应用观察[J].中国医药指南,2017,15(32):138-139. 被引量：2
-
4舒碧莹,蒋麒俊,蔡枫.ANCA、IL-1、IL-6、TNF-α四项检测诊断类风湿性关节炎的研究进展[J].国际检验医学杂志,2019,40(4):448-452. 被引量：21
-
5张盛,蔡旗旗,郑寿浩,杨志辉.局部枸橼酸抗凝下血浆置换治疗ANCA相关性血管炎合并弥漫性肺出血5例[J].中国乡村医药,2019,26(10):48-49.
-
6王毅.探讨免疫抑制剂在治疗原发性小血管炎中的临床应用价值[J].中国冶金工业医学杂志,2020,37(2):226-227.
-
1彭澎.终于等到你：HPV疫苗[J].大众健康,2016,0(9):34-36.
-
2曾平,苏金梅,张文.韦格纳肉芽肿合并肺隐球菌病1例[J].中华临床免疫和变态反应杂志,2011,5(3):243-246.
-
3李云婷,侯天文,张健,龙建国.从韦格纳肉芽肿病人鼻腔分泌物中检出蜂房哈夫尼亚菌1例[J].医学理论与实践,2003,16(11):1316-1316. 被引量：4
-
4常静.促进对罕见遗传性疾病的认知[J].中华医学信息导报,2008,23(22):7-7.
-
5治疗铁失调症可从基因入手[J].中华中医药学刊,2008,26(6):1292-1292.
-
6施诗.预防房颤血栓形成 新药Pradaxa被获准上市[J].心血管病防治知识,2011(1):63-63.
-
7朱爱萍,胡学芳,李小峰,王彩虹,侯云霞,吕志勤,张琳,郭存九.蛋白酶3抗原的提取纯化及鉴定[J].中华检验医学杂志,2006,29(8):695-696.
-
8Garewal M,Selhorst J.B,王孝文.锁骨下动脉剥离与神经系统3处梗死[J].世界核心医学期刊文摘（神经病学分册）,2006,2(5):22-22.
-
9张晓桐.FDA将调查Bayer避孕药致血栓风险[J].心血管病防治知识,2011(8):43-43.
-
10熊海云,朱有华.免疫细胞功能检测法及其在器官移植中应用的现状[J].中华器官移植杂志,2009,30(5):319-320. 被引量：1
